Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
The development of tumor necrosis factor alpha (TNF-) inhibitors is probably one of the most significant advancement in the management of a number of inflammatory rheumatic disorders to date. High efficacy of the treatment is associated with relatively rare and very heterogeneous adverse reactions....
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Termedia Publishing House
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/c12f29a7f5784476be57d07b8b576008 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!